Phospholipid N-methylation as a signal transduction mechanism in normal and failing hearts

Heart Failure Reviews

Volumn 2, Issue 1, 1997, Pages 43-53

  Panagia, Vincenzo ^a   Tappia, Paramjit S ^b   Dhalla, Naranjan S ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Cardiac Ca2+ transport; Cardiomyopathies; Heart hypertrophy and failure; Phospholipid N methylation; Signal transduction

Indexed keywords

PHOSPHOLIPID;

ADAPTATION; ARTICLE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CATALYSIS; ENZYME PURIFICATION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; METHYLATION; NONHUMAN; PHOSPHOLIPID METABOLISM; SIGNAL TRANSDUCTION;

EID: 0031390857     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009767320693     Document Type: Article

References (94)

1. Crews FT. Phospholipid methylation and membrane function. In: Kuo JF, ed. Phospholipids and Cellular Regulation. Volume 1. Boca-Raton, FL. CRC Press. 1985:131-135.
2. Vance DE, Ridgway ND. The methylation of phosphatidylethanolamine. Prog Lipid Res 1988;27:61-79.
3. Ridgway ND. Phosphatidylethanolamine N-methyltransferase. In: Vance DE, ed. Phosphatidylcholine Metabolism. Boca-Raton, FL: CRC Press. 1989:103-120.
4. Reitz RC, Mead DJ, Bjur RA, Greenhouse AH, Welch WH Jr. Phosphatidylethanolamine N-methytransferase in human red blood cell membrane preparations. J Biol Chem 1989;264:8097-8106.
5. Yamashita S, Oshima A, Nikawa J, Osaka K. Regulation of the Phosphatidylethanolamine methylation pathway in Saccharomices cerevisiae. Eur J Biochem 1982;128:589-595.
6. Dudeja PK, Foster ES, Brasitus TA. Synthesis of phosphatidylcholine by two distinct methyltransferases in rat colonic brush border membranes: Evidence for extrinsic and intrinsic membrane activities. Biochim Biophys Acta 1986;875:493-500.
7. Shinitzky M. Membrane fluidity and cellular functions. In: Shinitzky M, ed. Physiology of Membrane Fluidity. Boca-Raton FL: CRC Press. 1984:1-51.
8. Mato JM. Regulation of phospholipid methylation and its effect on membrane proteins. In: Watts A, DePont JJ, eds. Progress in Protein-Lipid-Interaction 2. Amsterdam: Elsevier Science 1986:267-302.
9. Panagia V, Ganguly PK, Dhalla NS. Characterization of heart sarcolemmal phospholipid methylation. Biochim Biophys Acta 1984;792:245-253.
10. Panagia V, Ganguly PK, Okumura K, Dhalla NS. Subcellular localization of phosphatidylethanolamine N-methylation in rat heart. J Mol Cell Cardiol 1985;17:1151-1159.
11. Okumura K, Panagia V, Beamish RE, Dhalla NS. Biphasic changes in the sarcolemmal phosphatidylethanolamine N-methylation activity in catecholamine-induced cardiomyopathy. J Mol Cell Cardiol 1987;19:357-366.
12. Panagia V, Okumura K, Shah KR, Dhalla NS. Modification of sarcolemmal phosphatidylethanolamine N-methylation during heart hypertrophy. Am J Physiol 1987;253:H8-H15.
13. Ganguly PK, Panagia V, Dhalla NS. Evidence for three catalytic sites in heart sarcolemmal phospholipid N-methylation. In: Dhalla NS, Hearse DJ, eds. Advances in Myocardiology. Volume 6. New York: Plenum 1985:157-164.
14. 2+ transport and phospholipid methyltransferase activity. J Cardiovasc Pharmacol 1994;24:286-292.
15. Heyliger CE, Prakash AR, McNeill JH. An assessment of phospholipid methylation in sarcolemma and sarcolplasmic reticulum of the aging myocardium. Biochim Biophys Acta 1988;960:462-465.
16. Hirata F, Axelrod Y. Phospholipid methylation and biological signal transmission. Science 1980;209:1082-1090.
17. Taira Y, Panagia V, Shah KR, Beamish RE, Dhalla NS. Stimulation of phospholipid N-methylation by isoproterenol in rat hearts. Circ Res 1990;66:28-36.
18. Hirata F, Strittmatter WJ, Axelrod J. β-Adrenergic receptor agonists increase phospholipid methylation, membrane fluidity and β-adrenergic receptor-adenylate cyclase coupling. Proc Natl Acad Sci USA 1979;76:368-372.
19. Zawad JS, Brown FC. Beta-adrenergic coupled phospholipid methylation: A possible role in withdrawal from chronic ethanol. Biochem Pharmacol 1984;33:3799-3865.
20. Hirata F, Tallman JF, Henneberry RC, Mallorga P, Strittmatter WJ, Axelrod J. Phospholipid methylation: A possible mechanism of signal transduction across biomembranes. Prog Clin Biol Res 1981;63:383-388.
21. Taira Y, Ganguly PK, Panagia V, Dhalla NS. Increased SR phospholipid N-methylation in skeletal muscle of diabetic rats. Am J Physiol 1988;255:E347-E352.
22. Vetter R, Dai J, Panagia V, Dhalla NS. Interactions between cyclic AMP-dependent protein phosphorylation and lipid transmethylation reactions in isolated porcine cardiac sarcolemma. Mol Cell Biochem 1989;91:51-61.
23. Meij JTA. Regulation of G protein function: Implications for heart disease. Mol Cell Biochem 1996;157:31-38.
24. Philipson KD. Sodium-calcium exchange in plasma membrane vesicles. Annu Rev Physiol 1985;47:561-571.
25. 2+ exchange in cardiac sarcolemmal vesicles by phospholipase D. J Biol Chem 1984;259:16-19.
26. 2+ exchanger of cardiac sarcolemma: Properties of the reconstituted system and tentative identification of the protein(s) responsible for the ?? exchange activity. J Biol Chem 1985;260:13321-13327.
27. 2+ permeability of cardiac sarcolemmal vesicles. J Biol Chem 1985;260:9666-9671.
28. Ashavaid TF, Colvin RA, Messineo FC, MacAlister T, Katz AM. Effects of fatty acids on Na/Ca exchange in cardiac sarcolemmal membranes. J Mol Cell Cardiol 1985;17:851-861.
29. 2+ exchange in heart sarcolemmal vesicles by phosphatidylethanolamine N-methylation. Eur J Biochem 1987;166:597-603.
30. 2+ exchange during the development of genetically determined cardiomyopathy. Biochem Biophys Res Commun 1985;133:491-497.
31. 2+ exchange in cardiac sarcolemmal vesicles. Exp Mol Pathol 1984;40:206-213.
32. Okumura K, Ogawa K, Sataka T. Phospholipid methylation in canine membranes: Relations to β-adrenergic receptors and digitalis receptors. Jpn Heart J 1983;24:215-225.
33. Okumura K, Panagia V, Beamish RE, Dhalla NS. Biphasic change in the sarcolemmal phosphatidylethanolamine N-methylation activity in catecholamine-induced cardiomyopathy. J Mol Cell Cardiol 1987;19:357-366.
34. Dhalla NS, Pierce GN, Panagia V, Singal PK, Beamish RE. Calcium movements in relation to heart function. Basic Res Cardiol 1982;77:117-139.
35. 2+ pumping ATPase of heart sarcolemma: Characterization, calmodulin dependence and partial purification. J Biol Chem 1981;256:3263-3270.
36. Hanahan DJ, Nelson DR. Phospholipids as dynamic participants in biological processes. J Lipid Res 1984;25:1528-1535.
37. 2+-AT-Pase activity associated with methylation of phospholipids in human erythrocytes. Biochem Biophys Res Commun 1979;88:147-153.
38. 2+) - ATPase activity in kidney cortex basolateral membranes. Biochim Biophys Acta 1983;727:185-195.
39. 2+-pump in rat heart sarcolemma by phosphatidylethanolamine N-methylation. Biochim Biophys Acta 1986;856: 383-387.
40. 2+ ATPase activities in heart sarcolemma upon phospholipid methylation. Mol Cell Biochem 1987;78:65-71.
41. Sulakhe PV, St Louis PJ. Passive and active calcium fluxes across plasma membranes. Prog Biophys Mol Biol 1985;35: 135-195.
42. Dhalla NS, Smith CI, Pierce GN, Elimban V, Makino N, Khatter JC. Heart sarcolemmal cation pump and binding sites. In: Rupp H, ed. The Regulation of Heart Function: Basic Concepts and Clinical Application. New York: Thieme. 1986:121-136.
43. +-ATPase, membrane fluidity and bile flow in rats with ethinyl estradiol-induced cholestasis. Hepatology 1983;3:12-17.
44. +-ATPase by S-adenosylmethionine. J Neurochem 1984;42:204-208.
45. 2+ stimulated adenosine triphosphatase of sarcoplasmic reticulum: Evidence for a disrupted lipid domain surrounding protein. Biochemistry 1985;24:433-442.
46. 2+-stimulated ATPase by phospholipid N-methylation in cardiac sarcoplasmic reticulum. Biochem Biophys Res Commun 1985;130:472-478.
47. Tarach JS. Histomorphological and ultrastructural studies on a rat myocardium in experimental conditions. Z Mikrosk Anat Forsch 1976;90:1145-1157.
48. Penpargkul S, Schaible T, Yipintsoi T, Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res 1980;47:911-921.
49. Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 1983;244:E528-E535.
50. Regan TJ. Congestive heart failure in the diabetic. Annu Rev Med 1983;34:161-168.
51. +-ATPase activity in diabetic rat heart. Am J Physiol 1983;245:C241-C247.
52. 2+-binding and composition of the cardiac sarcolemmal mem- brane in chronic diabetes. Proc Natl Acad Sci USA 1983;88:5412-5416.
53. Ganguly PK, Rice KM, Panagia V, Dhalla NS. Sarcolemmal phosphatidylethanolamine N-methylation in diabetic cardiomyopathy. Circ Res 1984;55:504-512.
54. Panagia V, Taira Y, Ganguly PK, Tung S, Dhalla NS. Alterations in phospholipid N-methylation of cardiac subcellular membranes due to experimentally induced diabetes in rats. J Clin Invest 1990;86:777-784.
55. Christensen NJ. Plasma norepinephrine and epinephrine in untreated diabetic, during fasting and after insulin administration. Diabetes 1974;23:1-8.
56. Heyliger CE, Rodrigues B, McNeill JH. Effect of choline and methionine treatment on cardiac dysfunction of diabetic rats. Diabetes 1986;35:1152-1157.
57. +-AT-Pase activity. Cell Biochem Funct 1992;10:95-101.
58. Hamaguchi T, Azuma J, Schaffer S. Interaction of taurine with methionine: Inhibition of myocardial phospholipid methyl-transferase. J Cardiovasc Pharmacol 1991;18:224-230.
59. Epand RM. Relationship of phospholipid haxagonal phases to biological phenomena. Biochem Cell Biol 1990;68:17-23.
60. 2+ transport systems. In: Kawai C, Abelman WH, eds. Pathogenesis of Myocarditis and Cardiomyopathy: Recent Experimental and Clinical Studies. Tokyo: U. of Tokyo Press. 1987:135-147.
61. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291-306.
62. Corder DW, Heyliger CE, Beamish RE, Dhalla NS. Defects in the adrenergic receptor-adenylate cyclase system during development of catecholamine-induced cardiomyopathy. Am Heart J 1984;107:537-542.
63. Flamigni F, Guarnieri C, Caldarera CM. Heart ornithine decarboxylase from control and isoproterenol-treated rats: Kinetic properties, multiple forms and subcellular distribution. Gen Pharmacol 1986;17:31-36.
64. Hirata F, Axelrod J. Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity. Nature 1978;275:219-220.
65. Sastry BVR, Statham CN, Meeks RG, Axelrod J. Changes in phospholipid methyltransferase and membrane microviscosity during induction of rat liver cytochrome P450 by phenobarbital and 3-methylcholanthrene. Pharmacology 1981; 23:211-222.
66. Sole MJ, Factor SM. Hamster cardiomyopathy: A genetically-transmitted sympathetic dystrophy? In: Beamish RE, Panagia V, Dhalla NS, eds. Pathogenesis of Stress-Induced Heart Disease. Boston: Martinus Nijhoff. 1987:34-43.
67. Okumura K, Panagia V, Jasmin G, Dhalla NS. Sarcolemmal phospholipid N-methylation in genetically determined hamster cardiomyopathy. Biochem Biophys Res Commun 1987; 143:31-37.
68. 2+ exchange during the development of genetically determined cardiomyopathy. Biochem Biophys Res Commun 1985;133:491-497.
69. Lefrak EA, Pitha J, Rosenheim S, Gottleib JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:301-314.
70. Singal PK, Siveski-Iliskovic N, Li T, Seneviratne C. Cardiomyopathie due à 1' adriamycine et sa prévention. L' information Cardiologique 1995;19:289-302.
71. Kaneko M, Panagia V, Paolillo G, Majumder S, Ou C, Dhalla NS. Inhibition of cardiac phosphatidyletanolamine N-methylation by oxygen free radicals. Biochim Biophys Acta 1990;1021:33-38.
72. Siveski-Iliskovic N, Panagia V, Slezak S, Kumar D, Li T, Singal PK. Adriamycin depresses in vivo and in vitro phosphatidyletanolamine N-methylation in rat heart sarcolemma. Mol Cell Biochem 1997; In Press.
73. Spann JF Jr, Buccino RA, Sonnenblick EH, Braunwald E. Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and failure. Circ Res 1967;21:341-354.
74. Kunos G, Robertson B, Kan WH, Preiksaitis H, Mucci L. Adrenergic reactivity of the myocardium in hypertension. Life Sci 1978;22:847-859.
75. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR. Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 1977;252:2787-2789.
76. Limas C, Limas CJ. Reduced number of β-adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 1978;83:710-714.
77. Woodcock EA, Funder JN, Johnston CJ. Decreased cardiac β-adrenoreceptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res 1979;45:560-565.
78. Limas CJ. Effect of phospholipid methylation on β-adrenergic receptors in the normal and hypertrophied rat myocardium. Circ Res 1980;47:536-541.
79. Panagia V, Okumura K, Shah KR, Dhalla NS. Modification of sarcolemmal phosphatidylethanolamine N-methylation during heart hypertrophy. Am J Physiol 1987;253:H8-H15.
80. 2+-ATPase activities in hypertrophied heart. J Appl Cardiol 1986;1:447-467.
81. 2+-binding in hypertrophied myocardium. Can J Cardiol 1985;1:328-339.
82. Carafoli E. How calcium crosses plasma membranes including the sarcolemma. In: Opie LH, ed. Calcium Antagonists and Cardiovascular Disease. New York: Raven Press. 1984:29-41.
83. Limas CJ. Increased phospholipid methylation in the myocardium of hypertrophied rats. Biochim Biophys Acta 1980;632:254-259.
84. Frieden HA, Goa KL, Beufield P. S-Adenosyl-L-methionine: A review of its pharmacological properties and therapeutic potential in liver dysfunction and effective disorders in relation to its physiological role in cell metabolism. Drugs 1989;38:389-416.
85. Gupta MP, Panagia V, Dhalla NS. Phospholipid N-methylation-dependent alterations of cardiac contractile function by L-methionine. J Pharmacol Exp Ther 1988;245:664-672.
86. 2+. Circ Res 1995;77:80-87.
87. Chapman RE, Tunstall J. The calcium paradox of the heart. Progr Biophys Mol Biol 1987;50:67-96.
88. Ruigrok TJC. The calcium paradox and the heart. In: Parratt JR, ed. Control and Manipulation of Calcium Movement. New York: Raven Press. 1985:341-365.
89. Zimmerman ANE, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 1966;211:646-647.
90. Meij JTA, Panagia V. Catecholamines and heart disease: Status of phospholipid signalling pathways. In: Ganguly PK, ed. Catecholamines and Heart Disease. Boca-Raton, FL: CRC Press. 1990:245-266.
91. 2+-deprived rat hearts. Circ Res 1981;48:17-24.
92. 2+ transport in hearts due to induction of calcium paradox. Circ Res 1988;63:313-321.
93. Persad S, Panagia V. Abnormal synthesis of N-methylated phospholipids during calcium paradox of the heart. J Mol Cell Cardiol 1995;27:579-587.
94. Ou C, Meij JTA, Panagia V. Sarcolemmal phosphatidylethanolamine N-methylation is depressed in the ischemic-reperfused heart. (Abstract) J Mol Cell Cardiol 1996;28:129.